Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

Clinical trial NCT00077779 · COMPLETED

Trial details

NCT number: NCT00077779
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2003-07-01
Enrollment: 854

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.